Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amylx Pharmaceuticals Inc (AMLX) vs Teucrium Wheat Fund (WEAT) Price & Performance

Amylx Pharmaceuticals IncTrade
Teucrium Wheat FundTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs Teucrium Wheat Fund — how do they compare? Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B), while Teucrium Wheat Fund trades at $24.01. The key difference: Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Teucrium Wheat Fund nearer its low. Which is the better fit depends on your goals.

AMLXWEAT
Market Cap
$2.64B
Sector
HealthCommodities - Metals/Agriculture
52-Week High
$24.19$26.00
52-Week Low
$7.82$19.88
Enterprise Value
$2.39B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Amylx Pharmaceuticals Inc

AMLX trades at $22.82, down 5.66% on the day, with a bullish technical signal from moving averages and key support at $22. The company reported a net loss of -$144.74M for 2025, with negative ROE and ROA, but holds a $250.8M cash runway into 2028. The pivotal Phase 3 LUCIDITY trial for avexitide is set for a late August/early September 2026 readout, a key near-term catalyst.

Analyst consensus is strongly bullish with a $30.00 price target, though recent earnings misses and negative cash flow from operations in 2026 pose risks. The stock's outlook hinges on successful clinical trial results and the subsequent regulatory pathway for its lead endocrine asset.

Teucrium Wheat Fund

WEAT, the Teucrium Wheat Fund, trades at $23.91, up 0.8% on the day, with a neutral technical signal overall. Recent performance shows strength, gaining 9.9% over the past month and 25% year-to-date as of July 21, 2026 (Zacks Investment Research). Key support and resistance cluster around $24, while oscillators like the relative strength index indicate neutral momentum. The USDA's reduced wheat production outlook for 2026 to 1.56 billion bushels, below analyst expectations (WSJ, May 12, 2026), underscores supply-side influences.

Outlook remains tied to agricultural commodity cycles; inflation trends and crop forecasts drive volatility. Risks include weather disruptions and global demand shifts, but current sentiment is balanced with potential for further gains if supply constraints persist.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX

About Teucrium Wheat Fund

WEAT is a commodity ETF that provides exposure to the price of wheat futures. It employs a laddered strategy across multiple benchmark contracts to mitigate the effects of contango and roll costs inherent in agricultural futures trading.

Read more on WEAT